Millendo Completes Patient Recruitment for Pivotal Study of Livoletide in Prader-Willi Syndrome November 14, 2019
Millendo Reports Third Quarter 2019 Operating and Financial Results; Livoletide pivotal study in PWS completed recruitment and is on track to report topline results in 1H20; Nevanimibe Phase 2b study in CAH continues recruitment, topline results expected November 14, 2019
KalVista Provides Business Update; Phase 2 Clinical Trial in HAE Expected to Complete Enrollment in 2019 with Data in 2020; Phase 2 Clinical Trial Data in DME Expected This Quarter November 14, 2019
Bicycle Announces First Patient Dosed in Phase I/II Trial for Patients with Advanced Solid Tumors November 13, 2019
Bicycle Therapeutics Reports Third Quarter 2019 Financial Results and Corporate Update November 8, 2019
FDA Grants Fast Track Designation for the Development of Mitobridge’s ASP1128 for Patients at Risk for Acute Kidney Injury November 4, 2019
